Progression and regression of atherosclerosis in APOE3-Leiden transgenic mice: An immunohistochemical study

Atherosclerosis

Volumn 143, Issue 1, 1999, Pages 15-25

  Gijbels, Marion J J ^a,b   Van Der Cammen, Maarten ^a   Van Der Laan, Luc J W ^a   Emeis, Jef J ^c   Havekes, Louis M ^c   Hofker, Marten H ^b   Kraal, Georg ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c TNO   (Netherlands)

Author keywords

Atherosclerosis; Immunohistochemistry; Progression; Regression; Transgenic mice

Indexed keywords

APOLIPOPROTEIN E; CD3 ANTIGEN; CD4 ANTIGEN; CHOLESTEROL; MONOCLONAL ANTIBODY; TRIACYLGLYCEROL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; DIETARY INTAKE; FAT INTAKE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; AORTA; APOLIPOPROTEIN E3; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; CELL ADHESION MOLECULES; CHOLESTEROL; CHOLESTEROL, DIETARY; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; FEMALE; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICE; MICE, TRANSGENIC; RECEPTORS, IMMUNOLOGIC; RECEPTORS, SCAVENGER; T-LYMPHOCYTES; TRIGLYCERIDES;

EID: 0033030088     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00263-9     Document Type: Article

References (46)

1. Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240:1988;622.
2. Weisgraber K.H. Apolipoprotein E: structure function relationships. Adv. Protein Chem. 45:1994;249.
3. Mahley R.W., Rall S.C. Jr. Type III hyperlipoproteinemia (dyslipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The Metabolic Basis of Inherited Disease. 6th edn:1989;1195 McGraw-Hill, New York.
4. Mahley R.W., Innerarity T.L., Rall S.C. Jr., Weisgraber K.H., Taylor J.M. Apolipoprotein E: genetic variants provide insights into its structure and function. Curr. Opin. Lipidol. 1:1990;87.
5. De Knijff P., Van den Maagdenberg A.M.J.M., Stalenhoef A.F.H., Gevers Leuven J.A., Demacker P.N.M., Kuyt L.P., Frants R.R., Havekes L.M. Familial dysbetalipoproteinemia associated with apolipoprotein E3-Leiden in an extended multigeneration pedigree. J. Clin. Invest. 88:1991;643.
6. Van den Maagdenberg A.M.J.M., Hofker M.H., Krimpenfort P.J.A., de Bruijn I., van Vlijmen B., van der Boom H., Havekes L.M., Frants R.R. Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia. J. Biol. Chem. 268:1993;10540.
7. Van Vlijmen B.J.M., van den Maagdenberg A.M.J.M., Gijbels M.J.J., van den Boom H., HogenEsch H., Frants R.R., Hofker M.H., Havekes L.M. Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice. J. Clin. Invest. 93:1994;1403.
8. Groot P.H.E., Van Vlijmen B.J.M., Benson G.M., Hofker M.H., Schiffelers R., Vidgeon-Hart M., Havekes L.M. Quantitative assessment of aortic atherosclerosis in apo E3 Leiden transgenic mice and its relationship to serum cholesterol exposure. Arterioscl. Thromb. Vasc. Biol. 16:1996;926.
9. van Vlijmen B.J.M., Van't Hof H.B., Mol M.J.T.M., Van der Boom H., Van der Zee A., Frants R.R., Hofker M.H., Havekes L.M. Modulation of very low density protein production and clearance contributes to age- and gender-dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice. J. Clin. Invest. 97:1996;1184.
10. Nishina P.M., Verstuyft J., Paigen B. Synthetic low and high fat diets for the study of atherosclerosis in the mouse. J. Lipid Res. 31:1990;859.
11. Nishina P.M., Lowe S., Verstuyft J., Naggert J.K., Kuypers F.A., Paigen B. Effects of dietary fats from animal and plant sources on diet-induced fatty streak lesions in C57BL/6J mice. J. Lipid Res. 34:1993;1413.
12. Paigen B.A., Morrow A., Holmes P.A., Mitchell D., Williams R.A. Quantitative assessment of atherosclerosis in mice. Atherosclerosis. 68:1987;231.
13. Vliet van E., Melis M., Foidart M., Ewijk van W. Reticular fibroblasts in peripheral lymphoid organs identified by amonoclonal antibody. J. Histochem. Cytochem. 34:1986;883.
14. Vliet van E.E., Melis M., Ewijk van W. Marginal zone macrophages in the mouse spleen identified by monoclonal antibody. Anatomical correlation with a B-cell subpopulation. J. Histochem. Cytochem. 33:1985;40.
15. Bell M.D., Lopez-Gonzalez R., Lawson L., Hughes D., Fraser I., Gordon S., Perry V.H. Upregulation of the macrophage scavenger receptor in response to different forms of injury in the CNS. J. Neurocytol. 23:1994;605.
16. Crocker P.R., Freeman S., Gordon S., Kelm S. Sialoadhesin binds preferentially to cells of the granulocyte lineage. J. Clin. Invest. 95:1995;635.
17. Kraal G., Janse M. Marginal metallophilic cells of the mouse spleen identified by a monoclonal antibody. Immunology. 58:1986;665.
18. Kraal G., Rep M., Janse M. Macrophages in the T and B cell compartments and other tissue macrophages recognized by monoclonal antibody MOMA-2; an immunohistochemical study. Scand. J. Immunol. 26:1987;653.
19. Pierres A., Nagnet P., Van Agthoven A., Bekkhonchs F., Demiot F., Mishal Z., Smit-Verhulst A.M., Pierres M. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones. J. Immunol. 132:1984;2775.
20. Ledbetter J.A., Herzenberger L.A. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev. 47:1979;63.
21. Coffman R.L. Surface antigen expression and immunoglobulin gene rearrangement during mouse pre-B cell development. Immunol. Rev. 69:1982;5.
22. Duijvestein A.M., Kerkhove M., Bargatze R., Butzer E.C. Lymphoid tissue and inflammation specific endothelial cell differentiation defined by monoclonal antibodies. J. Immunol. 138:1987;713.
23. Ross R. Cell biology of atherosclerosis. Annu. Rev. Physiol. 57:1995;791.
24. Nakashima Y., Plump A.S., Raines E.W., Breslow J.L., Ross R. Apo E-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. 14:1994;133.
25. Reddick R.L., Zhang S.H., Maeda N. Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. Arterioscl. Thromb. 14:1994;141.
26. Qiao J.-H., Xie P.-Z., Fishbein M.C., Kreuzer J., Drake T.A., Demer L.L., Lusis A.J. Pathology of atheromatous lesions in inbred and genetically engineered mice. Genetic determination of arterial calcification. Arterioscl. Thromb. 14:1994;1480.
27. Ishibashi S., Goldstein J.L., Brown M.S., Herz J., Burns D.K. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J. Clin. Invest. 93:1994;1885.
28. Johnson R.C., Chapman S.M., Dong Z.M., Ordovas J.M., Mayadas T.N., Herz J., Hynes R.O., Schaefer E.J., Wagner D.D. Absence of P-selectin delays fatty streak formation in mice. J. Clin. Invest. 99:1997;1037.
29. Stary H.C. Macrophages, macrophage foam cells, and eccentic intimal thickening in the coronary arteries of young children. Atherosclerosis. 64:1987;91.
30. Katsuda S., Boyd H.C., Fligner C., Ross R., Gown A.M. Human atherosclerosis. III Immunocytochemical composition of lesions of young adults. Am. J. Pathol. 140:1992;907.
31. Stary H.C. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Atherosclerosis. 9:1989;1.
32. Matsumoto A., Naito M., Itakura H., Ikemoto S., Asaoka H., Hayakawa I., Kanamori H., Aburatani H., Takaku F., Suzuki H., Kobari Y., Miyai T., Takahashi K., Cohen E.H., Wydro R., Housman D.E., Kodama T. Human macrophage scavenger receptors: Primary structure, expression, and localization in atherosclerotic lesions. Proc. Natl. Acad. Sci. 87:1990;9133.
33. Krieger M., Herz J. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor related protein (LRP). Annu. Rev. Biochem. 63:1994;601.
34. Suzuki H., Kurihara Y., Takeya M., Kamada N., Kataoka M., Jishage K., Ueda O., Sakaguchi H., Higashi T., Suzuki T., Takashima Y., Kawabe Y., Cynshi O., Wada Y., Honda M., Kurihara H., Aburatani H., Doi T., Matsumoto A., Azuma S., Noda T., Toyoda Y., Itakura H., Yazaki Y., Horiuchi S., Takahashi K., Kruijt J.K., Van Berkel T.J.C., Steinbrecher U.P., Ishibashi S., Maeda N., Gordon S., Kodama T. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature. 386:1997;292.
35. Crocker P.R., Gordon S. Mouse macrophage hemagglutinin (sheep erythrocyte receptor) with specificity for sialylated glycoconjugates characterized by a monoclonal antibody. J. Exp. Med. 169:1989;1333.
36. Van den Berg T.K., Brevé J.J.P., Damoiseaux J.G.M.C., Döpp E.A., Kelm S., Crocker P., Dijkstra C.D., Kraal G. Sialoadhesin on macrophages: its identification as a lymphocyte adhesion molecule. J. Exp. Med. 176:1992;647.
37. Kraal G., Ter Hart H., Meelhuizen C., Venneker G., Claassen E. Marginal zone macrophages and their role in the immune response against T-independent type 2 antigens: modulation of the cells with specific antibody. Eur. J. Immunol. 19:1989;675.
38. Elomaa O., Kangas M., Sahlberg J., Tuukkanen J., Sormunen R., Liakka A., Thesleff I., Kraal G., Tryggvason K. A novel murine collagenous membrane protein structurally related with scavenger receptor and expressed by a subpopulation of macrophages. Cell. 80:1995;603.
39. Leboeuf R., Puppione D., Schumaker V., Lusis A. Genetic control of lipid transport in mice. I. Structural properties and polymorphisms of plasma lipoproteins. J. Biol. Chem. 258:1983;5063.
40. Lusis A.J., Taylor B.A., Quon D., Zollman S., Leboeuf R.C. Genetic factors controlling structure and expression of apolipoproteins B and E in mice. J. Biol. Chem. 262:1987;7594.
41. Paigen B., Morrow A., Brandon C., Mitchell D., Holms P. Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis. 57:1985;65.
42. Malinow M.R. Experimental models of atherosclerosis regression. Atherosclerosis. 48:1983;105.
43. Clarkson T.B., Bond M.G., Bullock B.C., McLaughlin K.I., Sawyer J.K. A study of atherosclerosis regression in Mucaca Mulatta. Exp. Mol. Pathol. 41:1984;96.
44. Wissler R.W., Vesselinovitch D. Can atherosclerosis plaques regress? Anatomic and biochemical evidence from nonhuman animal models. Am. J. Cardiol. 65:1990;33F.
45. Blankenhorn D.H. Can atherosclerotic lesions regress? Angiographic evidence in humans. Am. J. Cardiol. 65:1990;41F.
46. De Feyter P.J., Vos J., Deckers J.W. Progression and regression of the atherosclerotic plaque. Eur. Heart. J. 16:1995;26.